CliffBio
small molecule

TRACLEER

BOSENTAN

Loss of exclusivityDecember 2027latest FDA-listed patent expiry
CompanyActelion →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRACLEER
Active ingredientBOSENTAN
Strength32MG
Dosage formTABLET, FOR SUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2017
Marketing statusRX

Listed patents

PatentExpiresType
7959945December 2027product
8309126May 2026product

More from Actelion

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.